Philips was only interested on whether Painchek could be extended to use on delirious patients which is why PCK released that announcement saying they will be conducting studies to see if this was possible years ago. Like I told you then, the other external assessments will not only be subjective to the assessors but to the patient themselves which is why I said this was impossible. Same with the disability market.
Ann: Investor Webinar - Tuesday 31 January, page-3
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.98M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2502000 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 150000 | 1 |
View Market Depth
| Last trade - 10.06am 10/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable